Application of Lung-Targeted Lipid Nanoparticle-delivered mRNA of soluble PD-L1 via SORT Technology in Acute Respiratory Distress Syndrome
Theranostics · 2023 · 13 (14) · 4974-4992
DOI: 10.7150/thno.86466 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2023. Verfasst von Han Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong Univer…. Hauptthemen laut MEDLINE: Nanoparticles, Respiratory Distress Syndrome. Die Arbeit wurde bisher 26-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
- Department of Gastrointestinal Surgery, Renji Hospital Affiliated, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
- State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, 200433, China.
- Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
- Shanghai RNACure Biopharma Co., Ltd. Shanghai, 200438, China.
- Shanghai Frontiers Science Center of Cellular Homeostasis and Human Diseases. Shanghai, 200025, China.
Zitieren
APA
Sun, H., Zhang, Y., Wang, J., Su, J., Zhou, D., Yu, X., Xu, Y., & Yang, W. (2023). Application of Lung-Targeted Lipid Nanoparticle-delivered mRNA of soluble PD-L1 via SORT Technology in Acute Respiratory Distress Syndrome. Theranostics, 13(14), 4974-4992. https://doi.org/10.7150/thno.86466
Vancouver
Sun H, Zhang Y, Wang J, Su J, Zhou D, Yu X, et al. Application of Lung-Targeted Lipid Nanoparticle-delivered mRNA of soluble PD-L1 via SORT Technology in Acute Respiratory Distress Syndrome. Theranostics. 2023;13(14):4974-4992. doi:10.7150/thno.86466
BibTeX
@article{Sun2023,
author = {Sun, Han and Zhang, Yu and Wang, Jiahui and Su, Juncheng and Zhou, Dejian and Yu, Xiang and Xu, Yingjie and Yang, Wen},
title = {Application of Lung-Targeted Lipid Nanoparticle-delivered mRNA of soluble PD-L1 via SORT Technology in Acute Respiratory Distress Syndrome},
journal = {Theranostics},
year = {2023},
volume = {13},
number = {14},
pages = {4974--4992},
doi = {10.7150/thno.86466}
}
EUVIMED